Clinical Trial Update: Study of Lenalidomide With Vorinostat in Pediatric Patients With High Grade or Progressive CNS Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating lenalidomide with vorinostat in pediatric high-grade or progressive CNS tumors; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Tumors

Drugs mentioned

• Lenalidomide (lenalidomide)
• Vorinostat (vorinostat)

Snippet

Sponsor: Johns Hopkins All Children's Hospital | Conditions: Central Nervous System Tumors | Phase 1 | Status: TERMINATED | Results posted: 2021-04-05